STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
131
13F, latest reported quarter
What the filings say about CXM
Insiders, 180 days
-$4.3M net sold
1 buyer · 7 sellers · 16% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$3.1M
9 notices
Sprinklr insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Sprinklr, Inc. insiders sold a net $4.3M of stock across 291 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 63.3% of the 237,088 shares held after it.
No other insider bought within 30 days.
131 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WARD JR STEPHEN M bought about $850.5K of CXM on Oct 13, 2026, the largest insider purchase at the company since 2022; 131 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Sep 16, 2026.
The trade is 6.6% of the 3,069,659 shares held after it.
5 other insiders sold within 30 days.
131 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO READ RORY P sold about $1.1M of CXM under a 10b5-1 plan on Oct 1, 2026; 5 other insiders sold within 30 days and 131 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 10, 2026.
The trade is 4.7% of the 550,733 shares held after it.
5 other insiders sold within 30 days.
131 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: GENERAL COUNSEL AND CORP. SEC. Scott Jacob sold about $144.8K of CXM on Sep 16, 2026; 5 other insiders sold within 30 days and 131 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Sep 15, 2026.
The trade is 3.8% of the 785,150 shares held after it.
5 other insiders sold within 30 days.
131 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Misra Amitabh sold about $164.4K of CXM under a 10b5-1 plan on Sep 16, 2026; 5 other insiders sold within 30 days and 131 funds added in the latest 13F quarter.
38 earlier Form 4 trades (code P or S) here by this insider (38 sales), the last on Jun 16, 2026.
The trade is 0.7% of the 735,253 shares held after it.
5 other insiders sold within 30 days.
131 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Thomas Ragy sold about $30.3K of CXM on Sep 16, 2026; 5 other insiders sold within 30 days and 131 funds added in the latest 13F quarter.
291 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CXM planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
RORY READ
Filed 2026-10-01
$1.0M
JOY CORSO
Filed 2026-09-16
$189.5K
SANJAY MACWAN
Filed 2026-09-16
$38.5K
AMITABH MISRA
Filed 2026-09-16
$164.4K
RORY P READ
Filed 2026-09-16
$809.6K
CXM mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Bushido Capital US SMID Cap Equity ETF
$2.6M position · as of 2026-07-31
1.4%
WisdomTree Cloud Computing Fund
$3.0M position · as of 2026-06-30
1.2%
State Street(R) SPDR(R) S&P(R) Software & Services ETF
$2.8M position · as of 2026-06-30
0.7%
Monteagle Opportunity Equity Fund
$113.1K position · as of 2026-05-31
0.7%
VictoryShares Small Cap Free Cash Flow ETF
$3.9M position · as of 2026-06-30
0.6%
Pacer US Small Cap Cash Cows Growth Leaders ETF
$172.1K position · as of 2026-07-31
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Thomas
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$12.4M
$13.6M
$5.2M
-29%
-45%
2022
$8.2M
$2.2M
$5.1M
-44%
-52%
2021
$1.1M
$74.2M
$949.4K
-36%
-26%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.3M sold by insiders over 180 days, 131 funds added last quarter, $3.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$872.9M
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM CXM
FY Jan 2026
$857.2M
FY Jan 2025
$796.4M
FY Jan 2024
$732.4M
FY Jan 2023
$618.2M
FY Jan 2022
$492.4M
Jul 2026
$213.7M
Apr 2026
$219.5M
Jan 2026
$220.6M
Oct 2025
$219.1M
Jul 2025
$212.0M
Apr 2025
$205.5M
Jan 2025
$202.5M
Oct 2024
$200.7M
At each fiscal year end
Single quarter
Net margin, TTM
+2.7%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM CXM
FY Jan 2026
+2.7%
FY Jan 2025
+15.3%
FY Jan 2024
+7.0%
FY Jan 2023
-9.0%
FY Jan 2022
n/a
Jul 2026
+3.3%
Apr 2026
+1.9%
Jan 2026
+4.1%
Oct 2025
+1.3%
Jul 2025
+5.9%
Apr 2025
-0.8%
Jan 2025
+48.7%
Oct 2024
+5.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$127.7M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM CXM
FY Jan 2026
$157.8M
FY Jan 2025
$71.8M
FY Jan 2024
$62.9M
FY Jan 2023
$20.6M
FY Jan 2022
-$39.1M
Jul 2026
$17.8M
Apr 2026
$70.0M
Jan 2026
$20.1M
Oct 2025
$19.8M
Jul 2025
$34.4M
Apr 2025
$83.5M
Jan 2025
$4.6M
Oct 2024
$8.2M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2022-01-31 (54 months older than the period end) plus current 2022-01-31 (54 months older than the period end); equity 2026-07-31
Debt to equity CXM
FY Jan 2026
0.00x
FY Jan 2025
0.00x
FY Jan 2024
0.00x
FY Jan 2023
0.00x
FY Jan 2022
0.00x
Jul 2026
0.00x
Apr 2026
0.00x
Jan 2026
0.00x
Oct 2025
0.00x
Jul 2025
0.00x
Apr 2025
0.00x
Jan 2025
0.00x
Oct 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt CXM
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.4%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity CXM
FY Jan 2026
+3.8%
FY Jan 2025
+18.8%
FY Jan 2024
+8.4%
FY Jan 2023
-10.5%
FY Jan 2022
n/a
Jul 2026
+4.4%
Apr 2026
+5.1%
Jan 2026
+3.8%
Oct 2025
+21.3%
Jul 2025
+23.7%
Apr 2025
+17.5%
Jan 2025
+18.8%
Oct 2024
+7.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.2%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets CXM
FY Jan 2026
+1.9%
FY Jan 2025
+10.1%
FY Jan 2024
+4.6%
FY Jan 2023
-5.7%
FY Jan 2022
n/a
Jul 2026
+2.2%
Apr 2026
+2.5%
Jan 2026
+1.9%
Oct 2025
+11.1%
Jul 2025
+11.6%
Apr 2025
+9.5%
Jan 2025
+10.1%
Oct 2024
+4.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate 65%, not meaningful
Return on invested capital CXM
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
+6.6%
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
+5.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.9%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed CXM
FY Jan 2026
+6.1%
FY Jan 2025
+3.5%
FY Jan 2024
+5.3%
FY Jan 2023
-9.4%
FY Jan 2022
-24.2%
Jul 2026
+7.9%
Apr 2026
+8.5%
Jan 2026
+6.1%
Oct 2025
+6.3%
Jul 2025
+5.9%
Apr 2025
+2.4%
Jan 2025
+3.5%
Oct 2024
+5.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
66.90x
close 2026-10-23 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing CXM
FY Jan 2026
70.89x
FY Jan 2025
19.80x
FY Jan 2024
69.33x
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
63.60x
Apr 2026
41.00x
Jan 2026
70.89x
Oct 2025
18.83x
Jul 2025
20.48x
Apr 2025
19.23x
Jan 2025
19.80x
Oct 2024
46.44x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value CXM
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield CXM
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -77%, PEG needs growth
PEG, trailing CXM
FY Jan 2026
n/a
FY Jan 2025
0.13x
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
0.12x
Jul 2025
0.14x
Apr 2025
0.21x
Jan 2025
0.13x
Oct 2024
1.02x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CXM ranks highest on financial health (99th percentile) and profitability (62nd), and lowest on risk and compliance (36th), among Software & IT peers.
Profitability
62
Inputs
Return on equity+4.4% · 57 pct, sector of 286
Return on assets+2.2% · 63 pct, sector of 381
Return on invested capitaleffective tax rate 65%, not meaningful
Return on capital employed+7.9% · 67 pct, sector of 294
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 288
Cash flow to debtno debt to cover
Growth
50
Inputs
Revenue growth, YoY+7.6% · 46 pct, sector of 480
Backlog growth, YoY+11.1% · 54 pct, sector of 182
Insider conviction
55
Inputs
Net Form 4 buying (codes P and S), 180d-$2.8M · 41 pct, sector of 285
Insider buyers, 180d1 · 69 pct, sector of 290
Institutional and government
60
Inputs
Funds adding, latest quarter131 · 60 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
36
Inputs
Short interest, % of float+9.7% · 27 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+12.0% · 45 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CXM filings, in plain words
Are Sprinklr insiders buying or selling CXM?
In the 180 days to 2026-10-27, Sprinklr insiders were net sellers, a net $4.3M: $850.5K of purchases and $5.1M of sales reported on Form 4, by 1 buyer and 7 sellers.
Are there planned insider sales of CXM?
Yes. 9 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $3.1M of stock; the latest, by RORY READ, was filed 2026-10-01.
Read the full summary
In the 180 days to 2026-10-27, Sprinklr insiders were net sellers of CXM, a net $4.3M across purchases and sales reported on Form 4 by 1 buyer and 7 sellers. 16% of the 19 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 9 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $3.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.